We also show that miR-22 is a tumor repressor and that PU.1-miR-22-MECOM regulation is involved in AML development; moreover, we demonstrate that reintroduction of miR-22 relieves the differentiation blockage and inhibits the growth of AML bone marrow blasts. Here, SPI1 is linked to acute myeloid leukemia.